echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Tiger Pharma acquired 70% of the shares of South Korean companies and seized the cro resources in Asia Pacific Region

    Tiger Pharma acquired 70% of the shares of South Korean companies and seized the cro resources in Asia Pacific Region

    • Last Update: 2015-06-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: Bio exploration announced in the evening of June 8, 2015 On June 6, Hong Kong Tiger Pharmaceutical Technology Co., Ltd., a wholly-owned subsidiary of the company, signed the share acquisition agreement with the counterparty leenos Corp (a listed company registered in South Korea with the stock code of 039980 KS), which is intended to acquire the subsidiary of leenos Corp with 27 billion won 70415 ordinary shares of dreamcis Inc., accounting for 70% of the total shares of dreamcis Inc It is reported that the transaction price of the target company's shares sold by the seller is 383441.03 won per share, with 70415 ordinary shares totaling about 27 billion won According to the latest exchange rate, it is about 1.48 yuan Dreamcis Inc is a cro company registered in Korea It was established in April 2000 Its main business is clinical trial research services and EDC (electronic document systems of clinical trials) Tiger pharmaceutical said that the signing of the intent agreement is conducive to the company to further seize the cro resources in the Asia Pacific region, further enhance the strategic positioning of the company's international multi center clinical trials, and lay the foundation for the company's next industrial layout.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.